Abstract
Using the National Health Insurance Research Database of Taiwan, the authors identified 1136 patients taking fixed-dose combination and 4544 patients taking free combinations of an angiotensin II receptor blocker and a dihydropyridine calcium channel blocker from January 2009 to December 2012. At a mean follow-up of 2.1 years, the fixed-dose combination was associated with improved medication adherence and persistence and better survival free from major adverse cardiac events and hospitalization for heart failure compared with the free combination regimens.
| Original language | English |
|---|---|
| Pages (from-to) | 983-989 |
| Number of pages | 7 |
| Journal | Journal of Clinical Hypertension |
| Volume | 19 |
| Issue number | 10 |
| DOIs | |
| State | Published - 10 2017 |
Bibliographical note
Publisher Copyright:©2017 Wiley Periodicals, Inc.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- angiotensin II receptor blocker
- dihydropyridine calcium channel blocker
- fixed-dose combination
- hypertension
- major adverse cardiac event
Fingerprint
Dive into the research topics of 'Medication compliance and clinical outcomes of fixed-dose combinations vs free combinations of an angiotensin II receptor blocker and a calcium channel blocker in hypertension treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver